Deep learning methods analyzed genomic data from whole blood samples and found differences in patients with Alzheimer’s disease.
We examined whether sera from recovered and naïve donors collected prior to, and following immunizations with existing mRNA vaccines, could neutralize the Wuhan-Hu-1 and B.1.351 variants.
The screening device leverages machine learning to identify certain biomarkers that may be indicative of COVID-19.
CMS has increased the amount Medicare will pay to providers for administering the COVID-19 vaccine.
A new sensor can monitor communications in the brain, speeding the development of Alzheimer’s precision medicine.
The company revealed new, encouraging data showing the vaccine may do a better-than-expected job at protecting patients against new variants.
Widely Used COVID-19 Vaccine May Be More Effective if Second Dose Is Given After a Long Wait Rather Than a Short One
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.